According to the new market research report Defibrillators Market is projected to reach USD 10,883.3 million by 2022 from USD 9,323.5 million in 2017 at a CAGR of 3.1%. North America dominated the global defibrillators market in 2017.
The advancements in S-ICDs and MRI-compatible Implantable Cardioverter Defibrillators (ICDs) & Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) are also expected to provide growth opportunities for players in the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=549
Top Market Players –
ZOLL Medical (US) held the leadership position in the global external defibrillators market.
The
company adopted new product launches, agreements, and partnerships as
its core business strategies to enhance its share in the global external
market. Other prominent players in the global external market included
Philips (Netherlands), Physio-Control (US), Cardiac Science (US), Nihon
Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana
(South Korea), METRAX (Germany), and METsis (Turkey).
• On the
basis of products, the defibrillators market is classified into
implantable cardioverter defibrillators (ICDs) and external
defibrillators. The ICDs product segment is bifurcated into transvenous
implantable cardioverter defibrillators (T-ICDs) and subcutaneous
implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is
further classified into single-chamber ICDs, dual-chamber ICDs, and
cardiac resynchronization therapy defibrillators (CRT-Ds).
• The
external defibrillators segment is further classified into manual
external defibrillators, automated external defibrillators (AEDs), and
wearable cardioverter defibrillators (WCDs). The external defibrillators
segment is expected to grow at the highest CAGR in the forecast period,
owing to the growing focus of key market players on developing
easy-to-use defibrillators, increasing support from governments to
install AEDs at public places, and rising adoption of WCDs.
• On the
basis of end users, the defibrillators market is segmented into
hospitals, clinics, and cardiac centers; pre-hospital care settings;
public access markets; alternate care facilities; and home care
settings. The public access markets segment is expected to grow at the
highest CAGR during the forecast period. Growth in this segment is
attributed to the development of advanced AEDs, rising cases of sudden
cardiac arrest at out-of-hospital settings, and increasing number of
public access defibrillation programs across the globe.
Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=549
Geographic Overview –
North
America is expected to account for the largest share of the global
defibrillators market in 2017, followed by Europe. The large share in
the North American region is mainly attributed to the rising incidence
of target diseases in the region, technological advancements in
defibrillators, and increasing number of public defibrillation programs
in the region. The large share of the North American market can mainly
be attributed to the continuous technological advancements and product
innovations, increasing number of public defibrillation programs, and
rising focus of key players to expand their business in the North
American region.
